Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2186 - Outcomes of Patients with Malignancy Admitted to the Intensive Care Units (ICU): a Prospective Study


10 Sep 2017


Poster display session


Supportive Care and Symptom Management


Hazem Assi


Annals of Oncology (2017) 28 (suppl_5): v543-v567. 10.1093/annonc/mdx388


H. Assi1, V. Nohra2, F. Sukhon1, N. Moukalled1, I. Bou Akl3, D. Mukherji1, M. Charafeddine1, N. Abdul Halim1, C. El Mouhayyar1, Y. Medlej1, P. Bou Khalil3

Author affiliations

  • 1 Hematology And Oncology, American University of Beirut Medical Center, 1107 2020 - Beirut/LB
  • 2 Internal Medicine, American University of Beirut Medical Center, 1107 2020 - Beirut/LB
  • 3 Pulmonary Medicine And Supportive Care, American University of Beirut Medical Center, 1107 2020 - Beirut/LB


Abstract 2186


Decisions regarding whether advanced cancer patients should be admitted to the intensive care units (ICU) is based on a complex suite of considerations, including short and long term prognosis, quality of life, and options to treat cancer. We set to describe demographic, clinical, and survival data and to identify factors associated with short and long term mortality in critically ill advanced cancer patients with non-elective admissions to general ICUs.


Critically ill adult cancer patients non-electively admitted to the ICUs at the American University of Beirut Medical Center (AUBMC) between August 2015 and 2016 were included. Demographic, clinical, and laboratory data was prospectively collected from first day of ICU admission up to 30 days after discharge. This study was observational and clinical decisions were left to the ICU team and attending physician.


91 patients were enrolled between August 2015 and 2016, with 41 patients (46%) dying in the ICU, and 12 patients (13.5%) within 30-days post-discharge. 7 patients were lost to follow-up. Mean OS was 137 days, and median OS was 31 days since date of admission to the ICU. Most common reasons for ICU admission were sepsis (68.5%) and respiratory failure (19%). Cox regression showed direct admission from the ED (2.4 times more likely to die), those with uncontrolled malignancies (1.8 times), chemotherapy within the last 30 days prior to ICU admission (2.3 times), and development of multi-organ failure (MOF) (2.5 times) in the ICU are major predictors of poor prognosis.


Our study showed receiving chemotherapy within thirty days prior to admission as a predictor of poor outcome in univariate and multivariate analyses. This has not been reported in a study population of this kind before. Also, many studies state that developing MOF, whether in the ICU or prior to admission negative prognostic factor. Finally, our study found that direct admission from the ED is a negative prognostic factor, which has only been reported for hematological malignancies in other studies. Thus, there is a need for the development of proper admission criteria for this population.

Clinical trial identification

Legal entity responsible for the study

American Unviersity of Beirut Medical Center




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.